YHYi He

Yi He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yi He has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Sheng Wang

    Department of Anesthesiology,Beijing Anzhen Hospital,Beijing,China; Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.,beijing,China; Capital Medical University,Beijing,China; Beijing Anzhen Hospital, Capital Medical University,Beijing,China; Department of Anesthesiology,Jinan University,Guangzhou,China; Department of Anesthesiology,Beijing Anzhen Hospital, Capital Medical University,Beijing,China, China

    7 shared publications
  • Zhengyuan Xia

    Department of Anesthesiology and Perioperative Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University

    3 shared publications
  • Dengwen Zhang

    Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences

    2 shared publications
  • Fuxia Yan

    Department of Anesthesiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    2 shared publications
  • Jiakai Lu

    Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China

    2 shared publications
  • Jiapeng Huang

    Department of Anesthesiology & Perioperative Medicine, University of Louisville, Louisville, KY

    2 shared publications

Latest Publications

  • Open Access

    Energy homeostasis is a conserved process: Evidence from Paracoccus denitrificans’ response to acute changes in energy demand

    by Raul Covian, Lanelle Edwards, Yi He, Geumsoo Kim, Carly Houghton, Rodney L. Levine, Robert S. Balaban

    Paracoccus denitrificans is a model organism for the study of oxidative phosphorylation. We demonstrate a very high respiratory capacity compared to mitochondria when normalizing to cytochrome aa3 content even in the absence of alternative terminal oxidases. To gain insight into conserved mechanisms of energy homeostasis, we characterized the metabolic response to K+ reintroduction. A rapid 3-4-fold increase in respiration occurred before substantial cellular K+ accumulation followed by a sustained increase of up to 6-fold that persisted after net K+ uptake stopped. Proton motive force (Δp) was slightly higher upon addition of K+ with ΔpH increasing and compensating for membrane potential (ΔΨ) depolarization. Blocking the F0F1-ATP synthase (Complex V) with venturicidin revealed that the initial K+-dependent respiratory activation was primarily due to K+ influx. However, the ability to sustain an increased respiration rate was partially dependent on Complex V activity. The 6-fold stimulation of respiration by K+ resulted in a small net reduction of most cytochromes, different from the pattern observed with chemical uncoupling and consistent with balanced input and utilization of reducing equivalents. Metabolomics showed increases in glycolytic and TCA cycle intermediates together with a decrease in basic amino acids, suggesting an increased nitrogen mobilization upon K+ replenishment. ATP and GTP concentrations increased after K+ addition, indicating a net increase in cellular potential energy. Thus, K+ stimulates energy generation and utilization resulting in an almost constant Δp and increased high-energy phosphates during large acute and steady state changes in respiration. The specific energy consuming processes and signaling events associated with this simultaneous activation of work and metabolism in P. denitrificans remain unknown. Nevertheless, this homeostatic behavior is very similar to that observed in mitochondria in tissues when cellular energy requirements increase. We conclude that the regulation of energy generation and utilization to maintain homeostasis is conserved across the prokaryote/eukaryote boundary.


  • Open Access

    Chinese Society of Anesthesiology Expert Consensus on Anesthetic Management of Cardiac Surgical Patients With Suspected or Confirmed Coronavirus Disease 2019

    by Yi He, Jinfeng Wei, Jinjun Bian, Kefang Guo, Jiakai Lu, Wei Mei, Jun Ma, Zhongyuan Xia, Meiying Xu, Fuxia Yan, et al.


  • Open Access

    Activation of autophagy inhibits nucleotide‐binding oligomerization domain‐like receptor protein 3 inflammasome activation and attenuates myocardial ischemia‐reperfusion injury in diabetic rats

    by Dengwen Zhang, Yi He, Xiaodong Ye, Yin Cai, Jindong Xu, Liangqing Zhang, Mingyi Li, Hao Liu, Sheng Wang, Zhengyuan Xia

    Aims/Introduction: Diabetic hearts are more vulnerable to ischemia‐reperfusion injury (I/RI). The activation of nucleotide‐binding oligomerization domain‐like receptor protein 3 (NLRP3) inflammasome can mediate the inflammatory process, and hence might contribute to myocardial I/RI. Activation of autophagy can eliminate excess reactive oxygen species and alleviate myocardial I/RI in diabetes. The present study aimed to investigate whether the activation of autophagy can alleviate diabetic myocardial I/RI through inhibition of NLRP3 inflammasome activation.Materials and Methods: A dose of 65 mg/kg streptozotocin was given by tail vein injection to establish a type 1 diabetes model in the rats. The left anterior descending coronary artery was ligated for 30 min followed by reperfusion for 2 h to establish a myocardial I/RI model. H9C2 cardiomyocytes were exposed to high glucose (33 mmol/L) and subjected to hypoxia–reoxygenation (6 h hypoxia followed by 4 h reoxygenation).Results: The diabetic rats showed significant inhibition of cardiac autophagy (decreased LC3‐II/I and increased p62) that was concomitant with increased activation of NLRP3 inflammasome (increased NLRP3, apoptosis‐related spots protein cleaved caspase‐1, interleukin‐18, interleukin‐1β) and more severe myocardial I/RI (elevated creatine kinase myocardial band, lactate dehydrogenase and larger infarct size). However, administration of rapamycin, an inhibitor of the autophagy, to activate autophagy resulted in the inhibition of NLRP3 inflammasome, and finally alleviated myocardial I/RI. In vitro, high glucose inhibited autophagy, while activating NLRP3 inflammasome in H9C2 cardiomyocytes and aggravating hypoxia–reoxygenation injury, but rapamycin reversed these adverse effects of high glucose.Conclusion: Activation of autophagy can suppress the formation of NLRP3 inflammasome, which in turn attenuates myocardial ischemia‐reperfusion injury in diabetic rats.


  • Intraoperative Transesophageal Echocardiography During Cardiovascular Surgery in China

    by Sheng Wang, Jinfeng Wei, Su Yuan, Yi He, Jiange Han, Jiakai Lu, Weiping Cheng, Jiapeng Huang


  • Open Access

    Activation of autophagy protects against myocardial ischemic reperfusion injury by inhibition of NLRP3 inflammasome‐mediated pyroptosis and inflammatory responses in diabetic rats

    by Sheng Wang, Dengwen Zhang, Xiaodong Ye, Yi He, Yin Cai, Zhengyuan Xia

    Background: Diabetic hearts are more vulnerable to ischemia/reperfusion injury (I/RI). The activation of NLRP3 inflammasome can mediate pyroptosis and inflammatory responses, which in turn exacerbate myocardial I/RI. Studies have demonstrated that activation of autophagy can eliminate excess reactive oxygen species (ROS) generation and alleviate myocardial I/RI in diabetes. However, the possible regulatory relationship between autophagy and NLRP3 inflammasome during diabetic myocardial I/RI is still unknown. Thus, the present study aimed to investigate whether the activation of autophagy can alleviate diabetic myocardial I/RI via inhibition of NLRP3 inflammasome‐mediated pyroptosis and inflammatory responses. Methods: A dose of 60 mg/kg streptozotocin was given via tail vein injection to establish type 1 diabetes model in rats. The left anterior descending branch of the coronary artery was ligated for 30 minutes and then allowed for reperfusion for 2 hours to establish rat myocardial I/RI model. RapaLink‐1(1mg/kg, i.p.), the third‐generation mTOR inhibitor, was given 72 hours before inducing myocardial I/RI. The degree of I/RI was assessed by the measurement of plasma CK‐MB, cTnT, LDH, and myocardial infarction size. The expression of NLRP3, ACS, cleaved Caspase‐1, interleulin (IL)‐18, and IL‐1β in the myocardium, and the levels of IL‐18 and IL‐1β in the plasma were tested to assess the activation of inflammasome and inflammatory responses. In addition, LC3 □/□ and p62 were measured to evaluate the level of autophagy. Results: Compared to non‐diabetic group, levels of cardiac autophagy were inhibited (decreased LC3 □/□ and increased p62) concomitant with activation of NLRP3 inflammasome (increased NLRP3, ASC, cleaved caspase‐1, IL‐18, IL‐1β) in diabetes. Also, more severe myocardial I/RI (elevated CK‐MB, cTnT, LDH, and larger infarction size) was seen in diabetic rats. Administration of RapaLink‐1 activated autophagy, inhibited NLRP3 inflammasome, and alleviated myocardial I/RI in diabetic rats. Conclusion: The activation of NLRP3 inflammasome in the diabetic myocardium may be attributable to the inhibition of autophagy. The activation of autophagy may inhibit NLRP3 inflammasome activation and consequently alleviate myocardial I/RI in diabetes. Support or Funding Information The study was supported by Guangdong Natural Science Foundation (2018A030313535, Guangdong, China) and HMRF (05161826) of Hong Kong. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

  • Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis

    by Xiao-Dong Ye, Yi He, Sheng Wang, Gordon T Wong, Michael G Irwin, Zhengyuan Xia

    Acute myocardial infarction (AMI) is a life-threatening event. Even with timely treatment, acute ischemic myocardial injury and ensuing ischemia reperfusion injury (IRI) can still be difficult issues to tackle. Apart from radiological and other auxiliary examinations, laboratory tests of applicable cardiac biomarkers are also necessary for early diagnosis and close monitoring of this disorder. Heart-type fatty acid binding protein (H-FABP), which mainly exists inside cardiomyocytes, has recently emerged as a potentially promising biomarker for myocardial injury. In this review we discuss the sensitivity and specificity of H-FABP in the assessment of myocardial injury and IRI, especially in the early stage, and its long-term prognostic value in comparison with other commonly used cardiac biomarkers, including myoglobin (Mb), cardiac troponin I (cTnI), creatine kinase MB (CK-MB), C-reactive protein (CRP), glycogen phosphorylase isoenzyme BB (GPBB), and high-sensitivity cardiac troponin T (hs-cTnT). The potential and value of combined application of H-FABP with other biomarkers are also discussed. Finally, the prospect of H-FABP is summarized; several technical issues are discussed to facilitate wider application of H-FABP in clinical practice.


  • Open Access

    N-Acetylcysteine Attenuates Diabetic Myocardial Ischemia Reperfusion Injury through Inhibiting Excessive Autophagy

    by Sheng Wang, Chunyan Wang, Fuxia Yan, Tingting Wang, Yi He, Haobo Li, Zhengyuan Xia, Zhongjun Zhang

    Background. Excessive autophagy is a major mechanism of myocardial ischemia reperfusion injury (I/RI) in diabetes with enhanced oxidative stress. Antioxidant N-acetylcysteine (NAC) reduces myocardial I/RI. It is unknown if inhibition of autophagy may represent a mechanism whereby NAC confers cardioprotection in diabetes. Methods and Results. Diabetes was induced in Sprague-Dawley rats with streptozotocin and they were treated without or with NAC (1.5 g/kg/day) for four weeks before being subjected to 30-minute coronary occlusion and 2-hour reperfusion. The results showed that cardiac levels of 15-F2t-Isoprostane were increased and that autophagy was evidenced as increases in ratio of LC3 II/I and protein P62 and AMPK and mTOR expressions were significantly increased in diabetic compared to nondiabetic rats, concomitant with increased postischemic myocardial infarct size and CK-MB release but decreased Akt and eNOS activation. Diabetes was also associated with increased postischemic apoptotic cell death manifested as increases in TUNEL positive cells, cleaved-caspase-3, and ratio of Bax/Bcl-2 protein expression. NAC significantly attenuated I/RI-induced increases in oxidative stress and cardiac apoptosis, prevented postischemic autophagy formation in diabetes, and reduced postischemic myocardial infarction (all p<0.05). Conclusions. NAC confers cardioprotection against diabetic heart I/RI primarily through inhibiting excessive autophagy which might be a major mechanism why diabetic hearts are less tolerant to I/RI.


  • Tryptophan probes reveal residue-specific phospholipid interactions of apolipoprotein C-III

    by Candace M. Pfefferkorn, Robert L. Walker, Yi He, James M. Gruschus, Jennifer C. Lee